(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VISIONIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VISIONIX

ST13

US500000097162724

Class

10

Filing

97162724

Registration

7221149

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

11/21/2023

Trademark type

Word

Nice classes

10

Filing date

12/08/2021

Registration date

11/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

11/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

2007-03-00

First use in commerce

2007-03-00

Drawing code

4

Owner type

99

Owner location

PONT DE L'ARCHE, FR

Examiner

CAHILL,CLARE GALLAGHER

Law office

L40

Current location

TMEG LAW OFFICE 104

Holders and representatives

Holders

L. O. (pessoa física)

Representatives

Jeannine A. Rittenhouse IPHORGAN LTD.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Ophthalmological diagnostic apparatus and instruments for use in in the complete medical analysis of the eye; ophthalmological diagnostic apparatus and instruments for detecting diseases of the eye; ophthalmological testing apparatus and instrumentseye testing apparatus; ophthalmological apparatus and instruments for detecting diseases of the eye; ophthalmo-meters; ophthalmoscopes; tonometers for measuring for medical use; medical diagnostic apparatus and instruments for the analysis of the tear film; medical apparatus and instruments for the examination and diagnosis of the anterior and posterior segment of the eye; medical diagnostic apparatus and instruments for the analysis and diagnosis of the anterior and posterior chamber of the eye; medical apparatus and instruments for the measurement of binocular dynamic refraction; medical apparatus and instruments for retinal exameye testing machines and apparatus; eye medical imaging apparatus; slit lamps for medical purposes; eye testing apparatusrefractometers for medical use; medical apparatus and instruments for measuring and testing visual acuity and vision; medical apparatus and instruments for corneal and lens examination and diagnostic analysis; eye examination medical apparatus and instruments; medical apparatus and instruments for treating eye disorders and defects of the eye; topographic medical apparatus and instruments for measuring the cornea; ophthalmological refractors for medical use

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/26/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/26/2023

ALIE

ASSIGNED TO LIE

07/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/20/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/22/2022

GNRT

NON-FINAL ACTION E-MAILED

09/22/2022

CNRT

NON-FINAL ACTION WRITTEN

09/22/2022

DOCK

ASSIGNED TO EXAMINER

09/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/14/2021

NWAP

NEW APPLICATION ENTERED

12/11/2021

Continuous trademark protection

Get notified about every new filing that threatens VISIONIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.